Aripiprazole in children and adolescents with conduct disorder: a single-center, open-label study.

Ercan, E S; Uysal, T; Ercan, E; Akyol  Ardic, U; Ardic, U A

Ercan, E S; Uysal, T; Ercan, E; Akyol Ardic, U; Ardic, U A.

Affiliation

Ercan ES; Department of Child and Adolescent Psychiatry, Ege University School of Medicine, Bornova, Izmir, Turkey.

Pharmacopsychiatry ; 45(1): 13-9, 2012 Jan.

Article in En | MEDLINE | ID: mdl-21993869

Subject(s)

Antipsychotic Agents/therapeutic use; Attention Deficit and Disruptive Behavior Disorders/drug therapy; Dopamine Agonists/therapeutic use; Piperazines/therapeutic use; Quinolones/therapeutic use; Adolescent; Antipsychotic Agents/adverse effects; Aripiprazole; Attention Deficit and Disruptive Behavior Disorders/psychology; Child; Diagnostic and Statistical Manual of Mental Disorders; Dopamine Agonists/adverse effects; Drug Monitoring; Drug Resistance; Female; Humans; Male; Piperazines/adverse effects; Psychiatric Status Rating Scales; Quinolones/adverse effects; Receptors, Dopamine D2/agonists; Serotonin 5-HT1 Receptor Agonists/adverse effects; Serotonin 5-HT1 Receptor Agonists/therapeutic use; Serotonin 5-HT2 Receptor Antagonists/adverse effects; Serotonin 5-HT2 Receptor Antagonists/therapeutic use; Severity of Illness Index; Turkey

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Piperazines / Antipsychotic Agents / Quinolones / Dopamine Agonists / Attention Deficit and Disruptive Behavior Disorders Type of study: Clinical_trials Limits: Adolescent / Child / Female / Humans / Male Country/Region as subject: Asia Language: En Journal: Pharmacopsychiatry Year: 2012 Document type: Article Affiliation country: Turkey Country of publication: Germany

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google